Status:
COMPLETED
Multiple Sclerosis and Overactive Bladder Treatment
Lead Sponsor:
Istanbul Medipol University Hospital
Conditions:
Neurogenic Bladder Dysfunction
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
Urinary symptoms are frequently seen in patients with Multiple Sclerosis (MS). Early evaluation of the patients in terms of the urinary system, planning the appropriate treatment and following up at r...
Detailed Description
Bladder dysfunction is one of the most disturbing symptoms of MS. The frequency of bladder dysfunction in patients with MS is reported to be %52-97. Urinary symptoms are among the initial symptoms in ...
Eligibility Criteria
Inclusion
- 18-65 years old
- Woman
- Volunteer to participate in the study
- Neurogenic overactive bladder due to MS
- EDSS \<7.0
- Not benefiting from pharmacological treatment
Exclusion
- With urinary tract infection
- Diagnosed with diabetes mellitus
- Using diuretic medication
- Using clean intermittent catheterization
- Having a history of different urological diseases
- Those who have conditions that would be contraindicated for electrical stimulation (pacemaker, brain pacemaker, prosthesis)
Key Trial Info
Start Date :
June 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 7 2022
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT05312138
Start Date
June 8 2021
End Date
December 7 2022
Last Update
May 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Medipol Mega University Hospital
Istanbul, Turkey (Türkiye)